Brief: RedHill Biopharma - Actively Discussing Potential Collaborations For Advancement Of Its Investigational Oral Drug, Opaganib
02/06/2026 13:10
BRIEF-RedHill Biopharma - Actively Discussing Potential Collaborations For Advancement Of Its Investigational Oral Drug, Opaganib June 2 (Reuters) - Redhill Biopharma Ltd 2RHy.F:
REDHILL BIOPHARMA - ADVANCING OPAGANIB OPTIONS FOR NOVEL DUAL HOST DIRECTED DIRECT ACTING ANTIVIRAL APPROACH FOR EBOLA OUTBREAK BIODEFENSE PLATFORMS
REDHILL BIOPHARMA - ACTIVELY DISCUSSING POTENTIAL COLLABORATIONS FOR ADVANCEMENT OF ITS INVESTIGATIONAL ORAL DRUG, OPAGANIB
Source text: [ID:n0001178913-26-003040]
Further company coverage: [2RHy.F]